The DOI matches its Crossref record; 61 of the 61 references it cites were found in a registry or an index.
Oxytocin Infusion Reduces Repetitive Behaviors in Adults with Autistic and Asperger's Disorders
Abstract
Autism is a neurodevelopmental disorder characterized by dysfunction in three core behavioral domains: repetitive behaviors, social deficits, and language abnormalities. There is evidence that abnormalities exist in peptide systems, particularly the oxytocin system, in autism spectrum patients. Furthermore, oxytocin and the closely related peptide vasopressin are known to play a role in social and repetitive behaviors. This study examined the impact of oxytocin on repetitive behaviors in 15 adults with autism or Asperger's disorder via randomized double-blind oxytocin and placebo challenges. The primary outcome measure was an instrument rating six repetitive behaviors: need to know, repeating, ordering, need to tell/ask, self-injury, and touching. Patients with autism spectrum disorders showed a significant reduction in repetitive behaviors following oxytocin infusion in comparison to placebo infusion. Repetitive behavior in autism spectrum disorders may be related to abnormalities in the oxytocin system, and may be partially ameliorated by synthetic oxytocin infusion.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Improvements in repetitive behaviors in adults with autism following oxytocin infusion have been demonstrated [169] as well as positive effects on social behaviors and cognition [170].”
From Consensus Paper: Pathological Role of the Cerebellum in Autism (2012) · cites this paper as [169]
In the citing paper
“The neuromodulator oxytocin (OT) has been shown to improve social deficits in both ASD and other disorders accompanied by social deficits (Guastella et al., 2010, 2010; Hollander et al., 2002, 2007; Yatawara et al., 2015; Young and Barrett, 2015).”
From Oxytocin enhances gaze-following responses to videos of natural social behavior in adult male rhesus monkeys (2016) · cites this paper as Hollander et al., 2002
In the citing paper
“reduce repetitive behaviors (Hollander et al., 2003)”
From Effects of intranasal oxytocin on social anxiety in males with fragile X syndrome (2012) · cites this paper as Hollander et al., 2003
In the citing paper
“This study demonstrated that administration of OT led to a decrease in a core ASD symptom, RRB.”
From Oxytocin and vasopressin systems in genetic syndromes and neurodevelopmental disorders (2014) · cites this paper as Hollander et al., 2003
In the citing paper
“Overall, these observed effects on repetitive behaviors are in line with previous trials with adult men with ASD showing beneficial effects of OT on repetitive behaviors after 4 h of intravenous OT administration [4] and after 6 weeks of daily administrations [8, 10].”
From Behavioral effects of multiple-dose oxytocin treatment in autism: a randomized, placebo-controlled trial with long-term follow-up (2020) · cites this paper as [4]
In the citing paper
“In this view, it appears that beneficial effects of OT treatment on repetitive behaviors were mostly demonstrated in studies that adopted assessments based on self-reports (current study, [4, 8]), whereas no beneficial effects were evident in studies adopting informant-based reports of repetitive behavior [9–14].”
From Behavioral effects of multiple-dose oxytocin treatment in autism: a randomized, placebo-controlled trial with long-term follow-up (2020) · cites this paper as [4]
In the citing paper
“There is both animal (Popik et al., 1992) and human (Hollander et al., 2007(Hollander et al., , 2003) ) research to suggest systemic OT can influence social behavior and cognition”
From Low dose intranasal oxytocin delivered with Breath Powered device dampens amygdala response to emotional stimuli: A peripheral effect-controlled within-subjects randomized dose-response fMRI trial (2016) · cites this paper as Hollander et al., 2003
In the citing paper
“oxytocin , relative to placebo, reduces repetitive stereotypic behaviors [172]”
From Social “wanting” dysfunction in autism: neurobiological underpinnings and treatment implications (2012) · cites this paper as [172]
Citations
Cites
Lord, C., Rutter, M., & Le Couteur, A. (1994) · Journal of Autism and Developmental Disorders · doi:10.1007/bf02172145 · Cited by 9,065
The neurobiology of attachment
Insel, T. R., & Young, L. J. (2001) · Nature Reviews Neuroscience · doi:10.1038/35053579 · Cited by 1,173
Social amnesia in mice lacking the oxytocin gene
Ferguson, J. N., Young, L. J., Hearn, E. F., Matzuk, M. M., Insel, T. R., & Winslow, J. T. (2000) · Nature Genetics · doi:10.1038/77040 · Cited by 1,130
A role for central vasopressin in pair bonding in monogamous prairie voles
Winslow, J. T., Hastings, N., Carter, C. S., Harbaugh, C. R., & Insel, T. R. (1993) · Nature · doi:10.1038/365545a0 · Cited by 948 · cited 1×
“For males, vasopressin has been shown to evoke partner preference and aggression after mating (Winslow et al, 1993).”
BackgroundOxytocin is required for nursing but is not essential for parturition or reproductive behavior.
Nishimori, K., Young, L. J., Guo, Q., Wang, Z., Insel, T. R., & Matzuk, M. M. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.21.11699 · Cited by 734
Plasma oxytocin levels in autistic children
Modahl, C., Green, L. A., Fein, D., Morris, M., Waterhouse, L., Feinstein, C., & Levin, H. (1998) · Biological Psychiatry · doi:10.1016/s0006-3223(97)00439-3 · Cited by 728
Insel, T. R., & Hulihan, T. J. (1995) · Behavioral Neuroscience · doi:10.1037/0735-7044.109.4.782 · Cited by 528
Oxytocin and autistic disorder: alterations in peptide forms
Green, L., Fein, D., Modahl, C., Feinstein, C., Waterhouse, L., & Morris, M. (2001) · Biological Psychiatry · doi:10.1016/s0006-3223(01)01139-8 · Cited by 404
Behavioral effects of intraventricularly administered vasopressin and vasopressin fragments
de Wied, D. (1976) · Life Sciences · doi:10.1016/0024-3205(76)90165-x · Cited by 359
Central Nervous System Effects of the Neurohypophyseal Hormones and Related Peptides
de Wied, D., Diamant, M., & Fodor, M. (1993) · Frontiers in Neuroendocrinology · doi:10.1006/frne.1993.1009 · Cited by 327
Flagged first, then by citations
Cited by
Sorted by citations
Items 101–200 of 704
Use of Antiepileptic Drugs for Nonepileptic Conditions: Psychiatric Disorders and Chronic Pain
Ettinger, A. B., & Argoff, C. E. (2007) · Neurotherapeutics · doi:10.1016/j.nurt.2006.10.003 · Cited by 157
Anagnostou, E., Soorya, L., Brian, J., Dupuis, A., Mankad, D., Smile, S., & Jacob, S. (2014) · Brain Research · doi:10.1016/j.brainres.2014.01.049 · Cited by 155
Tachibana, M., Kagitani-Shimono, K., Mohri, I., Yamamoto, T., Sanefuji, W., Nakamura, A., Oishi, M., Kimura, T., Onaka, T., Ozono, K., et al. (2013) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2012.0048 · Cited by 151
Miller, M., Bales, K. L., Taylor, S. L., Yoon, J., Hostetler, C. M., Carter, C. S., & Solomon, M. (2013) · Autism Research · doi:10.1002/aur.1270 · Cited by 151
Rutigliano, G., Rocchetti, M., Paloyelis, Y., Gilleen, J., Sardella, A., Cappucciati, M., Palombini, E., Dell’Osso, L., Caverzasi, E., Politi, P., et al. (2016) · Psychiatry Research · doi:10.1016/j.psychres.2016.04.117 · Cited by 149
“ordering, compulsion to tell/ask and touching) (Hollander et al., 2003), to modest (Anagnostou et al.”
Quintana, D. S., Alvares, G. A., Hickie, I. B., & Guastella, A. J. (2015) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2014.12.011 · Cited by 149
Yamasue, H., Yee, J. R., Hurlemann, R., Rilling, J. K., Chen, F. S., Meyer-Lindenberg, A., & Tost, H. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.3327-12.2012 · Cited by 149
Effects of intranasal oxytocin on 'compassion focused imagery'
Rockliff, H., Karl, A., McEwan, K., Gilbert, J., Matos, M., & Gilbert, P. (2011) · Emotion · doi:10.1037/a0023861 · Cited by 147
Buisman‐Pijlman, F. T. A., Sumracki, N. M., Gordon, J. J., Hull, P. R., Carter, C. S., & Tops, M. (2013) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2013.09.005 · Cited by 147
Low CSF oxytocin reflects high intent in suicide attempters
Jokinen, J., Chatzittofis, A., Hellström, C., Nordström, P., Uvnäs-Moberg, K., & Åsberg, M. (2012) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2011.07.016 · Cited by 143
Effects of intranasal oxytocin on social anxiety in males with fragile X syndrome
Hall, S. S., Lightbody, A. A., McCarthy, B. E., Parker, K. J., & Reiss, A. L. (2012) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2011.07.020 · Cited by 143
Oxytocin receptor knockout mice display deficits in the expression of autism-related behaviors
Pobbe, R. L. H., Pearson, B. L., Defensor, E. B., Bolivar, V. J., Young, W. S., Lee, H., Blanchard, D. C., & Blanchard, R. J. (2011) · Hormones and Behavior · doi:10.1016/j.yhbeh.2011.10.010 · Cited by 143
Lukas, M., & Neumann, I. D. (2012) · Behavioural Brain Research · doi:10.1016/j.bbr.2012.08.011 · Cited by 141
Ornoy, A., Weinstein‐Fudim, L., & Ergaz, Z. (2016) · Frontiers in Neuroscience · doi:10.3389/fnins.2016.00316 · Cited by 141
Oxytocin and experimental therapeutics in autism spectrum disorders
BARTZ, J., & HOLLANDER, E. (2008) · Progress in Brain Research · doi:10.1016/s0079-6123(08)00435-4 · Cited by 139
Self-citationOxytocin׳s role in anxiety: A critical appraisal
MacDonald, K., & Feifel, D. (2014) · Brain Research · doi:10.1016/j.brainres.2014.01.025 · Cited by 139
Search for autism loci by combined analysis of Autism Genetic Resource Exchange and Finnish families
Ylisaukko‐oja, T., Alarcón, M., Cantor, R. M., Auranen, M., Vanhala, R., Kempas, E., von Wendt, L., Järvelä, I. E., Geschwind, D. H., & Peltonen, L. (2005) · Annals of Neurology · doi:10.1002/ana.20722 · Cited by 139
Green, J., & Garg, S. (2018) · Journal of Child Psychology and Psychiatry · doi:10.1111/jcpp.12892 · Cited by 138
A review of valproate in psychiatric practice
Haddad, P. M., Das, A. K., Ashfaq, M., & Wieck, A. (2009) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425250902911455 · Cited by 138
The orgasmic history of oxytocin: Love, lust, and labor
Magon, N., & Kalra, S. (2011) · Indian Journal of Endocrinology and Metabolism · doi:10.4103/2230-8210.84851 · Cited by 137
Tian, J., Gao, X., & Yang, L. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.780407 · Cited by 136
Welch, M. G., Tamir, H., Gross, K. J., Chen, J. C., Anwar, M., & Gershon, M. D. (2008) · The Journal of Comparative Neurology · doi:10.1002/cne.21872 · Cited by 133
Yang, C.-J., Tan, H.-P., & Du, Y.-J. (2014) · Neuroscience · doi:10.1016/j.neuroscience.2014.02.021 · Cited by 132
The Psychopharmacology of Aggressive Behavior
Comai, S., Tau, M., & Gobbi, G. (2011) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e31823f8770 · Cited by 132
Gangadhar, B. N., Jayaram, N., Varambally, S. S., Behere, R. V., Venkatasubramanian, G., Arasappa, R., & Christopher, R. (2013) · Indian Journal of Psychiatry · doi:10.4103/0019-5545.116318 · Cited by 132
A double-blind randomized controlled trial of oxytocin nasal spray in Prader Willi syndrome
Einfeld, S. L., Smith, E., McGregor, I. S., Steinbeck, K., Taffe, J., Rice, L. J., Horstead, S. K., Rogers, N., Hodge, M. A., & Guastella, A. J. (2014) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.36653 · Cited by 131
Long-term exposure to intranasal oxytocin in a mouse autism model
Bales, K. L., Solomon, M., Jacob, S., Crawley, J. N., Silverman, J. L., Larke, R. H., Sahagún, E., Puhger, K. R., Pride, M. C., & Mendoza, S. P. (2014) · Translational Psychiatry · doi:10.1038/tp.2014.117 · Cited by 131
Martins, D., Mazibuko, N., Zelaya, F. O., Vasilakopoulou, S., Loveridge, J., Oates, A. E., Maltezos, S., Mehta, M. A., Wastling, S. J., Howard, M. A., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-14845-5 · Cited by 131
Aerosolized oxytocin increases cerebrospinal fluid oxytocin in rhesus macaques
Modi, M. E., Connor-Stroud, F., Landgraf, R., Young, L. J., & Parr, L. A. (2014) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2014.02.011 · Cited by 129
Oxytocin, vasopressin, and the motivational forces that drive social behaviors
Caldwell, H. K., & Albers, H. E. (2015) · Current Topics in Behavioral Neurosciences · doi:10.1007/7854_2015_390 · Cited by 129
Neuropeptides and the social brain: potential rodent models of autism
Lim, M. M., Bielsky, I. F., & Young, L. J. (2005) · International Journal of Developmental Neuroscience · doi:10.1016/j.ijdevneu.2004.05.006 · Cited by 129
Plasma and CSF oxytocin levels after intranasal and intravenous oxytocin in awake macaques
Freeman, S. M., Samineni, S., Allen, P. C., Stockinger, D., Bales, K. L., Hwa, G. G. C., & Roberts, J. A. (2016) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2016.01.014 · Cited by 128
Intranasal oxytocin selectively attenuates rhesus monkeys’ attention to negative facial expressions
Parr, L. A., Modi, M., Siebert, E., & Young, L. J. (2013) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2013.02.011 · Cited by 124
Autism and Oxytocin: New Developments in Translational Approaches to Therapeutics
Green, J. J., & Hollander, E. (2010) · Neurotherapeutics · doi:10.1016/j.nurt.2010.05.006 · Cited by 124
Self-citationAxelrod, F. B., Chelimsky, G. G., & Weese‐Mayer, D. E. (2006) · PEDIATRICS · doi:10.1542/peds.2005-3032 · Cited by 124
Oxytocin in the socioemotional brain: implications for psychiatric disorders
Kirsch, P. (2015) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2015.17.4/pkirsch · Cited by 123
Neurobiological correlates of social functioning in autism
Neuhaus, E., Beauchaine, T. P., & Bernier, R. (2010) · Clinical Psychology Review · doi:10.1016/j.cpr.2010.05.007 · Cited by 122
Overview of human oxytocin research
Kendrick, K. M., Guastella, A. J., & Becker, B. (2017) · Current Topics in Behavioral Neurosciences · doi:10.1007/7854_2017_19 · Cited by 121
The Psychopharmacology of Aggressive Behavior
Comai, S., Tau, M., Pavlovic, Z. M., & Gobbi, G. (2012) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e31824929d6 · Cited by 121
Parikh, M. S., Kolevzon, A. L., & Hollander, E. (2008) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2007.0041 · Cited by 121
Self-citationPharmacotherapy for the Core Symptoms in Autistic Disorder: Current Status of the Research
Farmer, C., Thurm, A. E., & Grant, P. (2013) · Drugs · doi:10.1007/s40265-013-0021-7 · Cited by 120
MDMA-assisted therapy: A new treatment model for social anxiety in autistic adults
Danforth, A. L., Struble, C. M., Yazar‐Klosinski, B., & Grob, C. S. (2015) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2015.03.011 · Cited by 120
Intranasal oxytocin in the treatment of autism spectrum disorders: A multilevel meta-analysis
Huang, Y., Huang, X., Ebstein, R. P., & Yu, R. (2021) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2020.12.028 · Cited by 119
Oxytocin and Autism: A Systematic Review of Randomized Controlled Trials
Preti, A., Melis, M., Siddi, S., Vellante, M., Doneddu, G., & Fadda, R. (2014) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2013.0040 · Cited by 118
Neurobiological Correlates of Autism: A Review of Recent Research
Penn, H. E. (2006) · Child Neuropsychology · doi:10.1080/09297040500253546 · Cited by 117
Jankowski, K. F., & Takahashi, H. (2014) · Psychiatry and Clinical Neurosciences · doi:10.1111/pcn.12182 · Cited by 115
Gordon, I., Jack, A., Pretzsch, C. M., Vander Wyk, B., Leckman, J. F., Feldman, R., & Pelphrey, K. A. (2016) · Scientific Reports · doi:10.1038/srep35054 · Cited by 114
Impact of prosocial neuropeptides on human brain function
MEYERLINDENBERG, A. (2008) · Progress in Brain Research · doi:10.1016/s0079-6123(08)00436-6 · Cited by 109
Oxytocin and Autism Spectrum Disorders
Yamasue, H., & Domes, G. (2017) · Current Topics in Behavioral Neurosciences · doi:10.1007/7854_2017_24 · Cited by 109
Quintana, D. S., Guastella, A. J., Westlye, L. T., & Andreassen, O. A. (2016) · Molecular Psychiatry · doi:10.1038/mp.2015.166 · Cited by 107
From Autism to Eating Disorders and More: The Role of Oxytocin in Neuropsychiatric Disorders
Romano, A., Tempesta, B., Bonaventura, M. V. M. D., & Gaetani, S. (2016) · Frontiers in Neuroscience · doi:10.3389/fnins.2015.00497 · Cited by 106
McNamara, I. M., Borella, A., Bialowas‐McGoey, L. A., & Whitaker‐Azmitia, P. M. (2007) · Brain Research · doi:10.1016/j.brainres.2007.10.063 · Cited by 106
A brief history of oxytocin and its role in modulating psychostimulant effects
Carson, D. S., Guastella, A. J., Taylor, E. R., & McGregor, I. S. (2013) · Journal of Psychopharmacology · doi:10.1177/0269881112473788 · Cited by 105
Oxytocin for the treatment of drug and alcohol use disorders
Lee, M. R., & Weerts, E. M. (2016) · Behavioural Pharmacology · doi:10.1097/fbp.0000000000000258 · Cited by 105
Revisiting the Relationship Between Autism and Schizophrenia: Toward an Integrated Neurobiology
de Lacy, N., & King, B. H. (2013) · Annual Review of Clinical Psychology · doi:10.1146/annurev-clinpsy-050212-185627 · Cited by 105
Genetic Influences on Social Cognition
Skuse, D., & Gallagher, L. (2011) · Pediatric Research · doi:10.1203/pdr.0b013e318212f562 · Cited by 105
Delivery of oxytocin to the brain for the treatment of autism spectrum disorder by nasal application
Tanaka, A., Furubayashi, T., Arai, M., Inoue, D., Kimura, S., Kiriyama, A., Kusamori, K., Katsumi, H., Yutani, R., Sakane, T., et al. (2018) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.7b00991 · Cited by 104
Quintana, D. S., Westlye, L. T., Rustan, Ø. G., Tesli, N., Poppy, C. L., Smevik, H., Tesli, M., Røine, M., Mahmoud, R. A., Smerud, K. T., et al. (2015) · Translational Psychiatry · doi:10.1038/tp.2015.93 · Cited by 103
Taylor, J. L., DaWalt, L. S., & Seltzer, M. M. (2013) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-013-2010-9 · Cited by 103
Bernaerts, S., Boets, B., Bosmans, G., Steyaert, J., & Alaerts, K. (2020) · Molecular Autism · doi:10.1186/s13229-020-0313-1 · Cited by 102
Quintana, D. S., Westlye, L. T., Alnæs, D., Rustan, Ø. G., Kaufmann, T., Smerud, K. T., Mahmoud, R. A., Djupesland, P. G., & Andreassen, O. A. (2016) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2016.04.010 · Cited by 102
Oxytocin and vasopressin systems in genetic syndromes and neurodevelopmental disorders
Francis, S. M., Sagar, A., Levin-Decanini, T., Liu, W., Carter, C. S., & Jacob, S. (2014) · Brain Research · doi:10.1016/j.brainres.2014.01.021 · Cited by 101
Prosocial effects of oxytocin in two mouse models of autism spectrum disorders
Teng, B. L., Nonneman, R. J., Agster, K. L., Nikolova, V. D., Davis, T. T., Riddick, N. V., Baker, L. K., Pedersen, C. A., Jarstfer, M. B., & Moy, S. S. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.04.038 · Cited by 98
Higashida, H., Lopatina, O., Yoshihara, T., Pichugina, Y. A., Soumarokov, A. A., Munesue, T., Minabe, Y., Kikuchi, M., Ono, Y., Korshunova, N., et al. (2010) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.2010.01976.x · Cited by 98
Evidence for Intranasal Oxytocin Delivery to the brain: Recent Advances and Future Perspectives
Quintana, D. S., Smerud, K. T., Andreassen, O. A., & Djupesland, P. G. (2018) · Therapeutic Delivery · doi:10.4155/tde-2018-0002 · Cited by 98
The amygdala and the relevance detection theory of autism: an evolutionary perspective
Zalla, T., & Sperduti, M. (2013) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2013.00894 · Cited by 98
Intranasal oxytocin effects on social cognition: A critique
Evans, S. L., Dal Monte, O., Noble, P., & Averbeck, B. B. (2014) · Brain Research · doi:10.1016/j.brainres.2013.11.008 · Cited by 97
Brugha, T. S., Doos, L., Tempier, A., Einfeld, S., & Howlin, P. (2015) · International Journal of Methods in Psychiatric Research · doi:10.1002/mpr.1466 · Cited by 97
Insular function in autism: Update and future directions in neuroimaging and interventions
Nomi, J. S., Molnar-Szakacs, I., & Uddin, L. Q. (2018) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2018.10.015 · Cited by 98
Aoki, Y., Watanabe, T., Abe, O., Kuwabara, H., Yahata, N., Takano, Y., Iwashiro, N., Natsubori, T., Takao, H., Kawakubo, Y., et al. (2015) · Molecular Psychiatry · doi:10.1038/mp.2014.74 · Cited by 95
Peptide therapeutics for CNS indications
McGonigle, P. (2012) · Biochemical Pharmacology · doi:10.1016/j.bcp.2011.10.014 · Cited by 95
Crystal structure of the human oxytocin receptor
Waltenspühl, Y., Schöppe, J., Ehrenmann, J., Kummer, L., & Plückthun, A. (2020) · Science Advances · doi:10.1126/sciadv.abb5419 · Cited by 95
Daughters, K., Manstead, A. S. R., Hubble, K., Rees, A., Thapar, A., & van Goozen, S. H. M. (2015) · PLOS ONE · doi:10.1371/journal.pone.0145104 · Cited by 92
“This scientific interest spans several fields, from clinical psychology, with respect to autism spectrum disorder [2, 3] and schizophrenia [4], to social psychology, with respect to intergroup relationships [5] and emotional processing [6].”
BackgroundValproate in bipolar disorder: 2000 onwards
Bowden, C. L., & Singh, V. K. (2005) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2005.00522.x · Cited by 92
A Comparison of Anticonvulsants in the Treatment of Impulsive Aggression.
Stanford, M. S., Helfritz, L. E., Conklin, S. M., Villemarette-Pittman, N. R., Greve, K. W., Adams, D., & Houston, R. J. (2005) · Experimental and Clinical Psychopharmacology · doi:10.1037/1064-1297.13.1.72 · Cited by 92
Kuppens, R. J., Donze, S., & Hokken‐Koelega, A. C. S. (2016) · Clinical Endocrinology · doi:10.1111/cen.13169 · Cited by 92
Alvares, G. A., Quintana, D. S., & Whitehouse, A. J. O. (2017) · Autism Research · doi:10.1002/aur.1692 · Cited by 91
Watson, K. K., & Platt, M. L. (2012) · Journal of Neurodevelopmental Disorders · doi:10.1186/1866-1955-4-21 · Cited by 91
Antiepileptic Medications in Autism Spectrum Disorder: A Systematic Review and Meta-Analysis
Hirota, T., Veenstra-VanderWeele, J. M., Hollander, E., & Kishi, T. (2013) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-013-1952-2 · Cited by 89
Self-citationGobbi, G., & Janiri, L. (2006) · Psychopharmacology · doi:10.1007/s00213-006-0317-3 · Cited by 88
Ayers, L. W., Missig, G., Schulkin, J. A., & Rosen, J. B. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2011.138 · Cited by 87
Male predominance in autism: neuroendocrine influences on arousal and social anxiety
Pfaff, D. W., Rapin, I., & Goldman, S. (2011) · Autism Research · doi:10.1002/aur.191 · Cited by 85
Olfaction in autism spectrum disorders: A systematic review
Tonacci, A., Billeci, L., Tartarisco, G., Ruta, L., Muratori, F., Pioggia, G., & Gangemi, S. (2015) · Child Neuropsychology · doi:10.1080/09297049.2015.1081678 · Cited by 85
Kojima, S., Stewart, R., Demas, G. E., & Alberts, J. R. (2012) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.2012.02280.x · Cited by 85
Munesue, T., Nakamura, H., Kikuchi, M., Miura, Y., Takeuchi, N., Anme, T., Nanba, E., Adachi, K., Tsubouchi, K., Sai, Y., et al. (2016) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2016.00002 · Cited by 84
Epigenetic evidence for involvement of the oxytocin receptor gene in obsessive–compulsive disorder
Cappi, C., Diniz, J. B., Requena, G. D. L., Lourenço, T., Lisbôa, B. C. G., Batistuzzo, M. C., Marques, A. H., Hoexter, M. Q., Pereira, C. A. D. B., Miguel, E. C., et al. (2016) · BMC Neuroscience · doi:10.1186/s12868-016-0313-4 · Cited by 84
Evidence-based pharmacotherapy for personality disorders
Ripoll, L. H., Triebwasser, J., & Siever, L. J. (2011) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145711000071 · Cited by 83
Dai, Y., Zhang, H., Schön, M., Böckers, T. M., Han, S., Han, J., & Zhang, R. (2018) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2018.00355 · Cited by 84
From intersubjectivity to subjectivity: the transformative roles of emotional intimacy and imitation
Zeedyk, M. S. (2006) · Infant and Child Development · doi:10.1002/icd.457 · Cited by 82
Nos, M., Cipriani, A., Biancosino, B., Grassi, L. G., & Barbui, C. (2006) · International Clinical Psychopharmacology · doi:10.1097/01.yic.0000224784.90911.66 · Cited by 82
Husarova, V. M., Lakatošová, S., Pivovarciova, A., Babinská, K., Bakoš, J., Durdiaková, J., Kubranská, A., Ondrejka, I., & Ostatníková, D. (2016) · Psychiatry Investigation · doi:10.4306/pi.2016.13.2.174 · Cited by 82
Examining Autism Spectrum Disorders by Biomarkers: Example From the Oxytocin and Serotonin Systems
Hammock, E. A. D., Veenstra-VanderWeele, J. M., Yan, Z., Kerr, T. M., Morris, M., Anderson, G. M., Carter, C. S., Cook, E. H., & Jacob, S. (2012) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2012.04.010 · Cited by 80
Neuroendocrine mechanisms of stress and social interaction: Implications for mental disorders
Heinrichs, M., & Gaab, J. (2007) · Current Opinion in Psychiatry · doi:10.1097/yco.0b013e3280146a13 · Cited by 79
Russell, J. D., Maguire, S., Hunt, G. E., Kesby, A., Suraev, A. S., Stuart, J. M., Booth, J., & McGregor, I. S. (2017) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2017.10.014 · Cited by 79
Oxytocin, sexually dimorphic features of the social brain, and autism
Yamasue, H., Kuwabara, H., Kawakubo, Y., & Kasai, K. (2009) · Psychiatry and Clinical Neurosciences · doi:10.1111/j.1440-1819.2009.01944.x · Cited by 78
Nicot, A. B., Otto, T. A., Brabet, P., & DiCicco-Bloom, E. M. (2004) · Journal of Neuroscience · doi:10.1523/jneurosci.1910-04.2004 · Cited by 78
Wahl, R. U. R. (2004) · Medical Hypotheses · doi:10.1016/j.mehy.2004.03.008 · Cited by 77
Functional Genomics of Social Recognition
Choleris, E., Kavaliers, M., & Pfaff, D. W. (2004) · Journal of Neuroendocrinology · doi:10.1111/j.0953-8194.2004.01178.x · Cited by 77
Oxcarbazepine in Patients With Impulsive Aggression
Mattes, J. A. (2005) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000186739.22395.6b · Cited by 76
Steroidal/neuropeptide interactions in hypothalamus and amygdala related to social anxiety
CHOLERIS, E., DEVIDZE, N., KAVALIERS, M., & PFAFF, D. (2008) · Progress in Brain Research · doi:10.1016/s0079-6123(08)00424-x · Cited by 75
Metadata
- Authors
- Hollander, E., Novotny, S., Hanratty, M., Yaffe, R., DeCaria, C. M., Aronowitz, B. R., & Mosovich, S.
- Affiliations
- Icahn School of Medicine at Mount Sinai (US)
- Corresponding author
- Hollander, Eric
- ORCID
- Hollander, Eric
- Venue
- Neuropsychopharmacology
- Published
- 2003-01
- Volume
- 28
- Issue
- 1
- Pages
- 193-198
- ISSN
- 0893-133X (ISSN-L)
- 1740-634X
- OpenAlex
- W2036441276
- Cited by
- 689
- References
- 60
- Citations by year
- 2026: 7 · 2025: 14 · 2024: 15 · 2023: 15 · 2022: 23 · 2021: 22 · 2020: 27 · 2019: 15 · 2018: 29 · 2017: 33 · 2016: 47 · 2015: 49 · 2014: 49 · 2013: 51 · 2012: 44
- FWCI
- 29.70
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Neuropsychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Alliance for Research on Schizophrenia and Depression
- National Institutes of Health
- National Center for Research Resources (5 M01RR00071, M01RR000071)
- Topics
- Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Neuroendocrine regulation and behavior
- Life Sciences › Neuroscience › Cognitive Neuroscience › Autism Spectrum Disorder Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Neurodevelopmental Disorders
- Keywords
- oxytocin, repetitive behavior, autism spectrum disorder, Asperger syndrome, autistic adults, oxytocin infusion, vasopressin, social behavior, self-harm, need to know, ordering behavior
- MeSH terms
- Adult, Autistic Disorder, Blood Pressure, Body Temperature, Double-Blind Method, Female, Humans, Infusions, Intravenous, Male, Oxytocin, Psychiatric Status Rating Scales, Pulse, Treatment Outcome, Asperger Syndrome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
